For now, no breast cancer that leaves the breast and the nodes for other organs appears to be curable, Winer said. The spread can happen more quickly for triple negative patients, and that's where the trial drugs may be able to help most. He was optimistic that potential new therapies such as the PARP inhibitors could improving the quality and quantity of life for many more patients.
"But we don't assume chemotherapy can't be effective for triple negative patients," said Winer. "Many women do exceedingly well."